PPARG, peroxisome proliferator activated receptor gamma, 5468
N. diseases: 877; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.900 | 0.902 | 122 | 1997 | 2018 | ||||||
|
0.851 | 0.160 | 3 | 12353341 | intron variant | C/T | snv | 0.26 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.800 | 1.000 | 2 | 2012 | 2018 | |||||||
|
0.882 | 0.080 | 3 | 12417048 | missense variant | T/A | snv |
|
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2002 | 2002 | ||||||||
|
0.851 | 0.160 | 3 | 12433900 | missense variant | C/T | snv |
|
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.800 | 1.000 | 2 | 2002 | 2002 | ||||||||
|
0.776 | 0.160 | 3 | 12434111 | missense variant | C/A;T | snv | 4.0E-06 |
|
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 4 | 2000 | 2014 | |||||||
|
0.500 | 0.840 | 3 | 12351626 | missense variant | C/G | snv | 0.11 | 8.9E-02 |
|
0.700 | 1.000 | 3 | 2012 | 2018 | |||||||
|
3 | 12408594 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 2 | 2015 | 2018 | |||||||||||
|
1.000 | 0.080 | 3 | 12293492 | intron variant | G/A | snv | 0.59 |
|
0.700 | 1.000 | 2 | 2016 | 2019 | ||||||||
|
1.000 | 0.040 | 3 | 12347064 | intron variant | A/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12385437 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
0.763 | 0.360 | 3 | 12311699 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12303137 | intron variant | A/G;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 3 | 12311827 | intron variant | T/C | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
0.925 | 0.120 | 3 | 12295008 | intron variant | G/A | snv | 8.8E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12302092 | intron variant | G/A | snv | 0.28 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12303231 | intron variant | C/G | snv | 9.2E-02 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.120 | 3 | 12311472 | intron variant | C/G | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12332833 | intron variant | C/G | snv | 2.9E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.040 | 3 | 12309724 | intron variant | A/G | snv | 3.8E-02 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12343043 | intron variant | G/A | snv | 0.25 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 3 | 12322138 | intron variant | G/A;T | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 3 | 12320430 | intron variant | T/C | snv | 0.27 |
|
Neoplasms | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
3 | 12357908 | intron variant | C/T | snv | 7.6E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 |